Evidence map›Paper›PMID 22475999›Full record

ReviewCurrent opinion in allergy and clinical immunology2012

Nonallergen-specific treatments for food allergy.

Jay A Lieberman, Julie Wang

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in allergy and clinical immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jay A LiebermanDivision of Allergy and Immunology, Department of Pediatrics, Elliot and Roslyn Jaffe Food Allergy Institute, Mount Sinai School of Medicine, Manhattan, New York City, New York, USA.
Julie Wang
Icahn School of Medicine at Mount Sinai · US

Funding

Immunological response to Chinese herbal medicine in food allergyK23AI083883 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WANG, JULIE · 2009 to 2013
$646k
NIAID NIH HHS AI083883NIAID NIH HHS K23 AI083883
6 · The paper itself

Abstract

purpose of reviewThis review summarizes recent reports on nonallergen-specific therapies for food allergy. These therapies are especially appealing for food allergy because unlike allergen-specific immunotherapy, they would allow the treatment of multiple food allergies in a single patient with one therapy. RECENT

findingsChinese herbal therapy, anti-IgE, probiotics, engineered lactic acid bacteria, and helminth therapy are all examples of allergen nonspecific therapies that have been investigated in recent years. Although some have only been studied in animal models of food allergy, some are undergoing rigorous, human clinical trials. SUMMARY: Increasing amounts of research are examining the efficacy and safety of nonallergen-specific therapies for food allergy. There is hope that clinicians will have effective treatments either as an alternative or as an adjunct to immunotherapy.

Indexed as

AnimalsAnti-Allergic AgentsAntibodies, Anti-IdiotypicAntibodies, Monoclonal, HumanizedClinical Trials as TopicDisease Models, AnimalDrugs, Chinese HerbalFood HypersensitivityHumansInfantMiceOmalizumabProbioticsTreatment OutcomeAnti-Allergic AgentsAntibodies, Anti-IdiotypicAntibodies, Monoclonal, HumanizedDrugs, Chinese HerbalOmalizumab

Identifiers

PMID22475999
PMCPMC4280662
OpenAlexW2005511633

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.